Skip to main content
. 2023 May 30;13:8743. doi: 10.1038/s41598-023-35070-2

Figure 5.

Figure 5

In vitro competitive pseudovirus assay for evaluating the binding affinities of spike variants. Schematic representation of in vitro competitive pseudovirus assay (A). The 293T-hACE2 cells was incubated with D614G spike pseudovirus (expressing luciferase and ZsGreen protein) and different concentration of spike variants. After 60–72 h, infectivity of D614G spike pseudovirus was visualized by expression of ZsGreen protein in fluorescent microscopy at different spike variant treatment (B). The percentage of D614G spike pseudovirus infectivity was quantified by internalized pseudovirus luciferase activity and inhibitory concentration 50 (IC50) of Wild (C) Delta (D) Omicron (E) C.1.2 (F) spike proteins were quantified using non-linear curve fitting models. Table of IC50 and IC90 values of each spike variants (G).